Angela Reiersen
Associate Professor of Psychiatry (Child)
- Phone: 314-286-1700
- Email: reiersena@nospam.wustl.edu
Additional Titles & Roles
- Director of First Contact Assessment Service
- Coursemaster of “Schizophrenia Precursors and Prodromal States” elective rotation for medical students, residents, and child psychiatry fellows.
Education & Training
- OtherM: Washington University in St Louis, 2006
- Fellowship: Washington University in St. Louis, 2004
- Residency: Washington University in St. Louis, 2002
- M.D.: University of Southern California, 1999
- B.S.: University of California Davis, 1994
Major Awards
- Hall of Fame: 100, Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP), For surpassing 100 lifetime peer reviews for JAACAP., 2024
- Dean’s Impact Award, Washington University School of Medicine, In recognition of superior efforts in response to the COVID-19 pandemic., 2023
- Clean-Up Hitter Award, Journal of the American Academy of Child & Adolescent Psychiatry (JAACAP), For cleaning up the peer review bases as an Editor-At-Large for Methodology & Statistics., 2018, 2019, 2020
- Elaine Schlosser Lewis Award for Research on ADHD, Recognizes the best research paper on ADHD published in JAACAP during the previous year., 2008
- Student Leadership Award, Academic Women’s Network, Washington University School of Medicine, For outstanding leadership in service to, or advancement of women within, the community., 2006
- The Eli Robins Award , Department of Psychiatry, Washington University in St. Louis, Awarded for excellence in clinical psychiatry, in teaching, and in research., 2004
Areas of Clinical Interest
Angela Reiersen, MD, First Contact Assessment Service focuses on evaluating children and adolescents with psychosis risk syndromes, genetic syndromes with psychiatric symptoms, and/or complex neurodevelopmental disorders (such as ADHD plus at least one additional neurodevelopmental or neurological disorder).
Research Interests
Much of my research has focused on epidemiology, genetics, and longitudinal course of childhood-onset psychiatric disorders, with emphasis on autism, ADHD, and tic disorders. Other research interests include childhood precursors to schizophrenia, early-onset schizophrenia, relationships between psychiatric disorders and neurological disorders, neurodevelopmental mechanisms involved in psychiatric disorders, and endoplasmic Reticulum (ER) disorders (including Wolfram syndrome and ryanodine receptor (RYR) calcium channel disorders). Since 2020, I have focused much of my research on COVID-19, including randomized clinical trials (RCTs) repurposing fluvoxamine–a sigma1 receptor (S1R) agonist and selective serotonin reuptake inhibitor (SSRI)–as a treatment for acute COVID-19 and long COVID.
Recent Publications
-
Sertraline modulates hippocampal plasticity via sigma 1 receptors, cellular stress and neurosteroids
Izumi, Y., Reiersen, A. M., Lenze, E. J., Mennerick, S. J. & Zorumski, C. F., Dec 2024, In: Translational psychiatry. 14, 1, 474.
-
Diagnostic Criteria for Primary Tic Disorders: More Reappraisal
Black, K. J., Grossen, S. C., Arbuckle, A. L., Bihun, E. C., Song, D. Y., Reiersen, A. M., Greene, D. J. & Schlaggar, B. L., Oct 2024, In: Movement Disorders. 39, 10, p. 1902-1903 2 p.
-
Correction to: A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications (Scientific Reports, (2024), 14, 1, (13462), 10.1038/s41598-024-64260-9)
Prasanth, M. I., Wannigama, D. L., Reiersen, A. M., Thitilertdecha, P., Prasansuklab, A., Tencomnao, T., Brimson, S. & Brimson, J. M., Dec 2024, In: Scientific reports. 14, 1, 16774.
-
We’ve all been wrong about provisional tic disorder
Grossen, S. C., Arbuckle, A. L., Bihun, E. C., Koller, J. M., Song, D. Y., Reiersen, A. M., Schlaggar, B. L., Greene, D. & Black, K., Oct 2024, In: Comprehensive Psychiatry. 134, 152510.